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Typically fatty acids (FA) exert differential immunomodulatory effects with n-3 [α-linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid
(DHA)] and n-6 [linoleic acid (LA) and arachidonic acid (AA)] exerting anti- and pro-inflammatory effects, respectively. This over-simplified interpretation is
confoundedby a failure to account for conversion of the parent FA (LA andALA) to longer-chain bioactive products (AA and EPA/DHA, respectively), thereby precluding
discernment of the immunomodulatory potential of specific FA. Therefore, we utilized the Δ6-desaturase model, wherein knockout mice (D6KO) lack the Fads2 gene
encoding for the rate-limiting enzyme that initiates FA metabolism, thereby providing a model to determine specific FA immunomodulatory effects. Wild-type (WT)
and D6KOmicewere fed one of four isocaloric diets differing in FA source (9 weeks): corn oil (LA-enriched), arachidonic acid single cell oil (AA-enriched), flaxseed oil
(ALA-enriched) ormenhaden fish oil (EPA/DHA-enriched). Splenicmononuclear cell cytokine production in response to lipopolysaccharide (LPS), T-cell receptor (TCR)
and anti-CD40 stimulationwas determined. Following LPS stimulation, AAwasmore bioactive compared to LA, by increasing inflammatory cytokine production of IL-6
(1.2-fold) and TNFα (1.3-fold). Further, LPS-stimulated IFNγ production in LA-fed D6KO mice was reduced 5-fold compared to LA-fed WT mice, indicating that
conversion of LA to AA was necessary for cytokine production. Conversely, ALA exerted an independent immunomodulatory effect from EPA/DHA and all n-3 FA
increased LPS-stimulated IL-10 production versus LA and AA. These data definitively identify specific immunomodulatory effects of individual FA and challenge the
simplified view of the immunomodulatory effects of n-3 and n-6 FA.
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Δ6-desaturase (D6D), encoded by the Fads2 gene, is the rate-
limiting enzyme that initiates the metabolism of the dietary essential
plant-derived n-6 and n-3 polyunsaturated fatty acids (PUFA), linoleic
acid (LA, 18:2n-6) and α-linolenic acid (ALA, 18:3n-3), respectively,
into their downstream long chain (LC) FA conversion products [1]. The
principal FA produced from the n-6 PUFA LA is arachidonic acid (AA,
20:4n-6, direct conversion product), whereas the n-3 PUFA ALA is
converted to eicosapentaenoic acid (EPA, 20:5n-3) and subsequently
to docosahexaenoic acid (DHA, 22:6n-3), with limited conversion
efﬁciency (in both rodents and humans) [2]. Speciﬁcally, in humans,
approximately up to 8% of ALA is converted to EPA andb0.1% is
converted to DHA [2–5]. In humans, essential PUFA intakes are
disproportionate; n-3 PUFA intake in the form of ALA is low, whereas
n-6 PUFA intake as LA is typically 5- to 20-fold greater [6–8] and this
surplus LA is either utilized for energy production/storage or
converted to AA. Differential effects of n-3 and n-6 PUFA are reported
following FA immune cell membrane incorporation, impactingCC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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production, lipid raft formation and signaling, leading to altered
gene expression and pathophysiological outcomes [9–15]. However,
dietary interventions attempting to discern speciﬁc protective and/or
therapeutic immunomodulatory effects of individual FA are con-
founded due to an inability to determine if the outcome is attributable
to the parent compound (LA or ALA), the downstream FA conversion
product (AA or EPA/DHA), or both.
To date, a gap exists with regard to our basic understanding of how
individual FA inﬂuence the diverse spectrum of immune cell effector
functions, in particular inﬂammatory cytokine production, wherein n-
3 PUFA are generally regarded to exert anti-inﬂammatory biological
effects and high intakes of n-6 PUFA typically promote a pro-
inﬂammatory phenotype [9,16]. Complicating this interpretation,
pro- and anti-inﬂammatory effects have been attributed to some n-6
PUFA-derived lipid mediators [17–19], and pro-resolving effects of
some AA-derived lipid mediators that down-regulate inﬂammatory
responses are also reported [20–24]. Therefore, this paradigm in FA
immunobiology remains controversial due to the growing evidence
that individual FA within these families can exert unique biological
effects. Using cytokine production as one aspect of immune compe-
tence that is inﬂuenced by dietary FA (assessed in the absence of a
confounding pathology), the majority of studies utilize human
mononuclear cells. In this context, EPA and DHA have been shown
to reduce peripheral blood mononuclear cell synthesis and/or
secretion of the inﬂammatory cytokines tumor necrosis factor (TNF)
α, interleukin (IL)-1β, IL-6 and/or interferon (IFN) γ [25–31], while
other studies have shown stimulatory [32] or no effect on these
parameters [33–35]. Conversely, AA has been shown to increase
immune cell gene expression of the inﬂammatory cytokines TNFα
and IL-1β [36], increase IL-6 secretion [37], and decrease anti-
inﬂammatory IL-10 secretion [38]. Conversely, human supplementation
with 1.5 g/day of AA showed no change in mononuclear cell
inﬂammatory cytokine secretion, although the sample size was limited
[39]. Data pertaining to the biological effects of the FA parent
compounds, ALA and LA, on cytokine production are less clear, and
tend to be confounded by downstream conversion to the more
biologically active FA products, as discussed above. Despite this
limitation, anti-inﬂammatory effects of ALA have been demonstrated
based on decreased serum levels ormononuclear cell secretion of TNFα,
IL-1β and/or IL-6 [40–42], whereas a stimulatory effect on macrophage
TNFα production has been reported [43]. Although these outcomes
cannot preclude the involvementof LCn-3 FA conversionproducts, they
demonstrate the potential for an independent biological effect of ALA.
Finally, despite a lack of independent LA-centered investigations, many
studies commonly use high LA diet formulations as the control diet for
comparison purposes to discern the biological effects of n-3 PUFA
[27,31,34,40–42], but fail to determine the independent effects of LA
compared to other FA. Few studies have attempted to address this
question and have shown LA to increase IL-6 bioactivity [31] or have no
effect on inﬂammatory cytokine secretion levels [35,41,44]. LA is
generally regarded as a pro-inﬂammatory n-6 PUFA, however, no
human clinical evidence supports this dogmatic view [45] and
protective effects of n-6 PUFA in inﬂammatory diseases have been
reported (reviewed elsewhere [46]). Collectively, these studies con-
found our understanding of the effects of speciﬁc FA and highlight that
this component of FA immunobiology (in both the healthy unchal-
lenged and disease states) requires revisitation, particularly since any
beneﬁcial or deleterious pro- or anti-inﬂammatory effects of individual
FA will be context-dependent. For example the anti-inﬂammatory
effects of n-3 PUFA are broadly interpreted to bebeneﬁcial,which is true
with respect to inﬂammatory pathologies and associated inﬂammation-
driven tissue damage, however, a robust inﬂammatory response
represents anormalphysiological function and is necessary in situations
such as opportunistic infections.The Δ6-desaturase knock-out (D6KO) mouse model provides a
means to determine the speciﬁc effects of individual FA and avoids the
confounding effect of FA conversion to LC products [47,48,49,50]. The
D6KO mouse exhibits similar FA conversion efﬁciency as humans [7],
thereby providing a mousemodel with translational utility. The D6KO
mouse lacks a functional copy of the Fads2 gene, rendering it unable to
produce the D6D protein [49,50], thereby blocking the rate-limiting
step in FA metabolism [1]. Therefore, D6KO mice represent a tool to
determine the effects of speciﬁc FA when provided in the diet and can
be used to delineate differences between parent chain FA and their
respective LC FA conversion products. In this model, WTmice provide
insight into the inﬂuence of FA conversion on study endpoints,
whereas comparison to D6KO mice demonstrates the effects of
individual FA (when conversion is inhibited). The objective of this
studywas to feedwild-type (WT) andD6KOmice speciﬁc FA-enriched
diets to assess the role of LA, AA, ALA and EPA/DHA on splenic
mononuclear cell cytokine production in response to an inﬂammatory
stimulus (lipopolysaccharide, LPS) and within speciﬁcally
activated immune cell compartments, namely T cells [via activation
of the T cell receptor (TCR)] and antigen presenting cells (APC, via
anti-CD40 ligation).
2. Materials and methods
2.1. Animals, housing and diets
The creation of the D6KO mouse was described previously [50]. Breeders were
transferred fromUniversity of Illinois at Urbana-Champaign to the University of Guelph
to establish a breeding colony. Heterozygous D6KOmale and female mice were bred to
generate WT and KO offspring and harems were fed a basal diet, which is a modiﬁed
AIN-93G diet with corn oil as the principal dietary fat source (D03090904P, Research
Diets, New Brunswick, NJ, USA). The pups were fed the same diet until they were
weaned and genotyped at 21 days of age, at which point male and female homozygous
D6KO and WT mice were placed on one of four isocaloric experimental diets, differing
only in their principal FA source: corn oil (LA-enriched), arachidonic acid single
cell oil (ARASCO) (AA-enriched), ﬂaxseed oil (ALA-enriched), and menhaden ﬁsh oil
(EPA/DHA-enriched). Diet formulations and diet FA compositions are shown in Tables 1
and 2, respectively. No diet was deﬁcient in LC PUFA (N20 carbon length), and therefore,
the LA and ALA-enriched diets were supplemented with a minimal amount (0.2% w/w)
of either AA or DHA from ARASCO and docosahexaenoic acid single cell oil (DHASCO),
respectively (DSM Nutritional Products Canada Inc., Ayr, ON, Canada), to prevent LC
PUFA deﬁciency in D6KO mice [47]. Speciﬁcally, the LA-enriched diet was devoid of AA
but was supplemented with DHASCO, whereas the ALA-enriched diet was devoid of
EPA/DHA but supplemented with ARASCO. All diet compositions were formulated to
contain AA, which was not supplemented in the EPA/DHA-enriched diet because
menhaden ﬁsh oil contains low levels of endogenous AA. The combination of these
dietary formulations and the use of WT and D6KO mice allows for the discernment of
the individual effects of speciﬁc FA. For example, in the LA-enriched diet, the speciﬁc
effects attributed to AA can be determined in WT mice, wherein the downstream
conversion of LA to AA is intact, versusD6KOmice wherein the downstream conversion
of LA to AA is inhibited). Mice were fed experimental diets for a total of 9 weeks. At
12 weeks of age, ﬁnal body weights were recorded and mice were euthanized using
CO2. During the experimental period, mice were housed as described [47], monitored
daily, and food intake and changes in bodyweight were recorded.Water and diets were
provided ad libitum and refreshed every 2–3 days. This investigation was approved by
the University of Guelph Animal Care Committee in accordance with the requirements
of the Canadian Council on Animal Care.
2.2. Genotyping
At 21days of age, mice were weaned and tail snips were obtained for DNA
extraction and PCR analysis to determine genotype as described [50]. The PCR primers
utilized were D6D WT forward (CGGTGGGAGGAGGAGTAGAAGAC); D6D WT reverse
(CCTCTCCCTGGTTACCTCCCTTC); D6D KO forward (GCTATGACTGGGCACAACAG); and
D6D KO reverse (TTCGTCCAGATCATCCTGATC) [47].
2.3. Fatty acid analysis by gas chromatography
Lipids were extracted from whole spleens (n=3–4/diet/genotype) and from two
individual pellets from each experimental diet using the Folch method [51]. FA methyl
esters were prepared as described previously [52] and separated on Agilent Technologies
7890 A GC System with DB-FFAP fused-silica capillary column (15 m, 0.1 μm ﬁlm
thickness, 0.1 mm i.d.; Agilent Technologies, Palo Alto, CA, USA). FA were identiﬁed by
comparing peak retention times with those of known standards (GLC463; Nu-Chek Prep,
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as percent of total.2.4. Splenic mononuclear cell isolation and stimulation
The spleen was selected for study as it combines innate and adaptive immunolog-
ical cells, whose coordinated responses are representative of systemic immune
competence [53]. Spleens were removed aseptically and pushed through a sterile
70 μm nylon cell strainer (BD Biosciences, Mississauga, ON, Canada) and a single-cell
mononuclear cell population was enriched by density gradient centrifugation using
Lympholyte-M (Cedarlane Laboratories, Burlington, ON, Canada). Cells were counted in
a hemocytometer and viability was assessed using trypan blue exclusion, which
exceeded 97% in all samples. Subsequently, cells were suspended in complete RPMI
1640 medium containing 2.05 mM L-glutamine (HyClone, South Logan, UT, USA)
supplemented with 10% v/v fetal bovine serum (FBS; low-endotoxin, Canadian origin,
Sigma-Aldrich, St. Louis, MO, USA), 25 mMHEPES (Irvine Scientiﬁc, Santa Ana, CA, USA)
and 1% v/v penicillin streptomycin (HyClone). 5 × 105 viable mononuclear cells were
added to each well of a 96-well ﬂat bottom plate (Sartedt, Montreal, QC, Canada). Cells
were incubated at 37 °C for 24 h under one of the following stimulation conditions:
unstimulated (complete RPMI media alone), lipopolysaccharide (LPS)-stimulated
(general inﬂammatory stimulus; 10 μg/ml, E. coli 055:B5; Sigma Aldrich) or T-cell
receptor (TCR)-stimulated [T cell-speciﬁc stimulus; 5 μg/mL of plate-bound anti-CD3
(clone 145-2C11; eBioscience, San Diego, CA, USA) plus 20 μg/mL of soluble anti-CD28
(clone 37.51; eBioscience)] or anti-CD40-stimulated (APC-speciﬁc stimulus; 10 μg/mL,
clone 1C10; eBioscience)which is expressed on B cells, macrophages and dendritic cells
and ligation induces amaturation signal to the APC [54]. Culture supernatantwas stored
at−80 °C to await analysis.2.5. Flow cytometry
Standard ﬂow cytometry staining procedures were performed as described [55]
and splenic mononuclear cells were stained with either 1 μg/ml of PE-anti-mouse
major histocompatibility class (MHC)-II (I-A) (clone NIMR-4; eBioscience), 1 μg/ml
of PE-anti-mouse CD4 (clone GK1.5; eBioscience), or 1 μg/ml of PE-anti-mouse CD8
(clone 53–6.7; eBioscience) antibodies for 30 min prior to ﬁxation in paraformaldehyde
(20 g/L) and samples were analyzed within 7 days on a Becton-Dickinson FACSCalibur
ﬂow cytometer equipped with BD CellQuest software. This strategy targeted the two
major immune cell compartments in the spleen, namely T cells (CD4+ and CD8+ T cell
subsets) and MHC II-expressing cells (which would include dendritic cells, macro-
phages and B cells) [56]. Representative histograms for each staining condition are
shown in Supplemental Fig. 1.2.6. Secreted cytokine analysis
Secreted levels of TNFα, IL-1β, IL-6, IL-10 and IFNγwere simultaneously measured
in each sample using the ProCartaPlex mouse basic kit (eBioscience) using the Bio-
Plex200 System and accompanying software package, Bio-Plex Manager 6.0 (Bio-Rad,
Hercules, CA, USA).2.7. Statistical analysis
Data were analyzed by two-way ANOVA (main effects: diet and genotype)
followed by least-squares means post-hoc test and normality was assessed using the
Shapiro–Wilk test. Differences were considered to be signiﬁcant with P≤ .05, and all
values are expressed as means with their standard errors. Statistical analyses were
conducted using the SAS system (SAS Institute, Cary, NC, USA) forWindows (version 9.1).3. Results
3.1. Mouse characteristics
Male and female mice were utilized in this study; however, there
was no statistical inﬂuence of sex on any of our endpoints assessed
(PN .05). Initial body weights did not differ between genotypes at the
start of the study (PN .05) and there was no difference in ﬁnal body
weight or food intake between any of the groups after 9 weeks of
dietary intervention (Supplemental Table 1). Further, the D6KO mice
grew normally and showed no phenotypic signs of FA deﬁciency such
as dermatitis or intestinal ulcers during the experimental period,
which has been shown to manifest in D6KO mice after longer
intervention periods [50].3.2. Splenic fatty acid composition
The splenic FA proﬁle of WT and D6KO mice following 9 weeks of
dietary intervention is shown in Table 3. As expected, WT and D6KO
mice fed the LA-enriched diet exhibited similar splenic tissue levels of
LA, whereas the D6KOmouse exhibited low AA levels compared to the
WT, indicative of impaired conversion of LA to AA. Unlike any other
diet utilized in this study, the LA-enriched diet is devoid of AA;
however, therewas a low level of AA tissue accumulation detectable in
D6KO mice (decreased by 74% compared to WT), which reﬂects
maternal carry over prior to the start of the dietary intervention. The
long term conservation of LC FA (i.e. AA and DHA) devoid in the diet of
D6KOmice in multiple tissues has been characterized previously [50],
and therefore, complete tissue AA depletion is not expected at
12 weeks of age. Preservation of tissue LC FA reﬂects the fundamental
role of these FA in membrane composition and cellular function [57].
There were signiﬁcantly higher levels of total n-3 PUFA, predomi-
nantly DHA but some accumulation of EPA and DPA was detected in
LA-fed D6KO mice compared to WT. This reﬂects the accumulation of
LC n-3 PUFA that were provided in the diet to prevent potential
confounding effects in our model due to a lack of any dietary N20
carbon FA (LA-enriched diet is devoid of AA) and the inability to
synthesize LC PUFA in the D6KO mouse. While it is possible that the
presence of some limited background amount of DHAmay have some
biological impact, it was the signiﬁcant absence of AA and presence of
LA in this dietary group that was being tested and would be the main
driver of any observed outcome.
In connection to this, a similar trend was observed in mice
consuming the ALA-enriched diet, wherein both genotypes had
similar tissue levels of ALA but compared to WT mice the D6KO mice
consuming this diet exhibited no (EPA) or very low levels of LC n-3
PUFA [DPA (decreased by 94%) and DHA (decreased by 89%)
versusWT] due to Fads2 deﬁciency and an inability to convert ALA to
EPA/DHA (Table 3). AA levels were not signiﬁcantly different between
WT and D6KO mice consuming the ALA-enriched diet, which was
supplemented with ARASCO to prevent deﬁciencies inN20 carbon
containing FA. In both cases, WT and D6KO mice fed the LA-enriched
and ALA-enriched diets, which contained LC PUFA from the comple-
mentary n-3 or n-6 family (in the form of DHASCO and ARASCO,
respectively), exhibited similar levels of total LC PUFA, indicating that
when FA conversion is inhibited dietary sources of LC PUFA are
preferentially retained regardless of PUFA class (i.e., n-3 or n-6 series),
which likely reﬂects a basic requirement for LC PUFA for optimal
membrane FA composition [57]. Furthermore, the addition of LC PUFA
is necessary to prevent the synthesis of potentially confounding PUFA
derived from the upregulation of delta-5 desaturase, which we have
shown can be prevented by addition of dietary LC PUFA [47,48].
Collectively, these data conﬁrm that the D6D enzyme was non-
functional in the D6KO mice compared to WT. These observations
validate our experimental approach and formulation of our experi-
mental diets given thatwhile N20 carbon chains are not essential, they
appear to be conditionally essential in theD6KOmouse, presumably to
maintain membrane ﬂuidity.
As expected in the two groups consuming diets already enriched in
either AA or EPA/DHA, respectively, tissue FA levels were similar
between WT and D6KO mice, since tissue FA accumulation was
dependent on dietary sources, not Fads2 enzyme function and
conversion form the parent FA. These data demonstrate that the
D6KOmouse performed as expected and that the dietary FA provided
were enriched in the target tissue being studied. Furthermore, the
levels of the n-6 FA, docosapentaenoic acid (22:5n-6), an indicator of
EPA/DHA deﬁciency, were either undetectable or very low and did not
differ between genotypes. This is particularly relevant in the LA and
AA-enricheddietary groups inwhich the diet also contained aminimal
amount of DHASCO to prevent such deﬁciency. Similarly, the levels of
Table 1
Diet composition ⁎
Diet constituents CO/DHASCO ARASCO/DHASCO Flaxseed
oil/ARASCO
Menhaden
oil
‘LA’ ‘AA’ ‘ALA’ ‘EPA/DHA’
Macronutrient (g %)
Protein 20 20 20 20
Carbohydrate 64 64 64 64
Fat 7 7 7 7
kcal/g 4 4 4 4
Ingredient (g/kg)
Casein 200 200 200 200
L-Cystine 3 3 3 3
Corn Starch 397.5 397.5 397.5 397.5
Maltodextrin 10 132 132 132 132
Sucrose 100 100 100 100
Cellulose, BW200 50 50 50 50
S10022G Mineral Mix 35 35 35 35
V10037 Vitamin Mix 10 10 10 10
Choline Bitartrate 2.5 2.5 2.5 2.5
TBHQ 0.014 0.014 0.014 0.014
Corn Oil 66.25 0 0 0
Flaxseed Oil 0 0 66.25 0
Menhaden Oil 0 0 0 70
ARASCO (40% AA) 0 66.25 3.75 0
DHASCO (40% DHA) 3.75 3.75 0 0
⁎ CO, corn oil; TBHQ, tertiary butylhydroquinone. Composition of AIN-93Gmodiﬁed diets
as provided bymanufacturer, Research Diets. Diet product numbers: CO/DHA (D12041402),
ARASCO/DHASCO (D12041406), Flaxseed oil/ARASCO (D12041404), Menhaden Oil
(D12041407). All diet compositions as % kcal: 20% protein, 64% carbohydrate, 16% fat.
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due to the presence of a minimal amount of ARASCO supplied in
the diet. These data demonstrate that the effects observed were not
due to a deﬁciency in the complementary essential FA pathway. The
total % PUFA measured within the spleen of WT and D6KO mice was
similar to the hepatic values reported previously in this mouse model
[47,48] and is reﬂective of the basal tissue level of total PUFA
membrane enrichment.
3.3. Changes in splenic immune cell populations
Changes in the percentage of speciﬁc T cell subsets (CD4+ and
CD8+ T cells) and MHC II+ (total antigen presenting cells) are shown
in Fig. 1, as staining intensities did not differ between any groups.
D6KO mice consuming the LA-enriched diet (i.e. devoid of AA) had a
reduced percentage of CD4+ T cells compared to the LA-WT (Fig. 1A).
Interestingly, in the AA group, there was no difference between WT
and KO, indicating that dietary repletion of AA could reverse the effect
of Fads2 deletion and subsequent AA insufﬁciency. There was noTable 2
Diet fatty acid composition ⁎
Fatty Acid
(% of total)
CO/DHASCO ARASCO/DHASCO Flaxseed
oil/ARASCO
Menhaden
oil
‘LA’ ‘AA’ ‘ALA’ ‘EPA/DHA’
18:2n6 52.4 6.9 14.8 2.2
18:3n3 1.0 0.3 54.6 1.9
20:4n6 0.0 38.2 2.3 1.8
20:5n3 0.0 0.0 0.0 15.0
22:6n3 2.0 2.1 0.0 11.6
% Saturated 15.7 21.4 10.3 33.5
% Monounsaturated 28.5 24.5 17.3 25.4
% Polyunsaturated 55.8 54.1 72.4 41.1
% n-6 Polyunsaturated 52.8 51.7 17.6 6.3
% n-3 Polyunsaturated 3.0 2.4 54.8 34.8
⁎ Fatty acid composition (%) of experimental diets. Lipids were extracted from two
individual pellets from each diet and analyzed by gas chromatography.difference between WT and D6KO splenic CD4+ T cell numbers in
either the ALA or EPA/DHA-enriched groups (PN .05). Independent of
genotype, mice consuming the EPA/DHA-enriched diet exhibited a
reduced percentage of CD4+ T cells compared to all other dietary
groups (Pb .05). Similarly, the percentage of splenic CD8+ T cells was
reduced in the EPA/DHA group compared to all other dietary groups
(Pb .05, Fig. 1B), whereas there was no effect of genotype on CD8+ T
cells. Finally, therewas no difference in the percentage of splenicMHC
II+ cells in any groups (PN .05, Fig. 1C).
3.4. Cytokine response to LPS-stimulation
Cytokine production in unstimulated mononuclear cell cultures
(independent of diet and/or genotype) was very low or undetectable,
and therefore, only the cytokine response to each stimulation
condition is shown. In response to LPS stimulation there was an
independent effect of diet on cytokine secretion (Pb .05, Fig. 2),
however, there was no independent effect of genotype or signiﬁcant
interaction term (diet x genotype) for any cytokines with the
exception of IFNγ. Cultures from D6KO mice fed the LA-enriched
diet (i.e., unable to convert LA to AA) exhibited a signiﬁcant 80%
reduction in IFNγ secretion compared to LA-fed WT mice (Fig. 2E).
The level of IFNγ produced in response to LPS did not differ between
AA-fedWT and D6KOmice. Moreover, the level of IFNγ production by
both theAA-fedWTandD6KOmicewas not statistically different from
WT LA-fed mice. These observations indicate that AA is the primary
inﬂammatory n-6 FA supporting increased IFNγ production, which
can be provided directly in the diet or through endogenous conversion
of LA to AA. Conversely, IFNγ secretion was reduced (independent of
genotype) by both ALA and EPA/DHA compared to LA-fed WT or AA-
fed mice.
For all other cytokines measured, independent of genotype,
comparison of both n-6 (LA and AA) versus n-3 (ALA and EPA/DHA)
FA-containing diets revealed a predominantly n-6 FA driven pro-
inﬂammatory cytokine secretion proﬁle. This was most apparent in
the AA-enriched diet, wherein secretion of TNFα, IL-1β and IL-6
was increased compared to both the ALA and EPA/DHA-enriched diets
(Fig. 2A–C). Cytokine secretion in the LA-enriched diet was either
blunted (IL-6, decreased by 24%; TNFα decreased by 18%) or
unchanged (IL-1β) compared to AA, indicating that the n-6 FA
conversionproduct AA ismore potently pro-inﬂammatory in response
to LPS versus the parent FA, LA. Moreover, with respect to TNFα
production, LA did not differ from either ALA or EPA/DHA,
which further supports the weaker inﬂammatory nature of LA
compared to AA. The effects of ALA and EPA/DHA did not differ
between genotypes for TNFα, IL-1β and IL-6. Given the inability to
convert ALA to EPA/DHA in this model, these observations demon-
strate an independent inhibitory effect of ALA that is equivalent to
EPA/DHA. Conversely, although production of the anti-inﬂammatory
cytokine IL-10was increased by both n-3 FA-containing diets, EPA/DHA
exhibited a more potent effect compared to ALA, whereas IL-10 levels
were signiﬁcantly decreased by the n-6 FA-containing diets, LA (58%)
and AA (59%), compared to EPA/DHA (Fig. 2D). Collectively, these data
demonstrate that in response to LPS stimulation, the longer chain
conversion products AA and EPA/DHA are more bioactive compared to
their respective parent chain FA.
3.5. Cytokine response to TCR-stimulation
Genotype had no effect on the cytokine response to TCR
stimulation and there were no signiﬁcant interaction terms (PN .05)
for any cytokinesmeasured; however, this responsewas differentially
affected by diet as shown in Fig. 3. IFNγ production was highest in the
AA-enriched group compared to all other FA and there was no
difference in IFNγ production between the LA, ALA and EPA/DHA
Table 3
Splenic fatty acid composition of total lipids in WT and D6KO mice ⁎
Fatty acid
(% composition)
Diet/genotype
CO/DHASCO ARASCO/DHASCO Flax/ARASCO Menhaden oil
‘LA’ ‘AA’ ‘ALA’ ‘EPA/DHA’
WT D6KO WT D6KO WT D6KO WT D6KO
n-6 Fatty acids
18:2n-6 16.8±2.2a 20.4±0.9b 2.5±0.2c 2.1±0.1c 6.4±0.4d 6.2±0.1d 1.8±0.07c 1.8±0.05c
20:4n-6 7.7±1.3a 2.0±0.2b 25.3±0.6c 26.4±0.6c 12.7±1.9d 16.7±1.2d 6.9±0.7a 7.7±0.2a
22:4n-6 1.2±0.2a 0.2±0.03b 5.2±0.3c 6.2±0.04d 1.7±0.2e 4.3±0.2f 0.6±0.03g 0.7±0.02g
22:5n-6 0.2±0.04 0 0.4±0.03 0 0.1±0.04 0 0.5±0.05 0.6±0.02
n-3 fatty acids
18:3n-3 0.2±0.05a 0.1±0.01a 0a 0a 5.4±0.7b 5.5±0.5b 0.3±0.03a 0.3±0.02a
20:5n-3 0.1±0.01a 0.8±0.08b 0c 0c 0.9±0.1b 0c 7.3±0.8d 6.5±0.5d
22:5n-3 0.5±0.03a 1.6±0.1b 0.3±0.04a 0.2±0.02a 3.4±0.4c 0.2±0.03a 4.9±0.4d 5.4±0.2d
22:6n-3 5.7±0.6a 12.3±0.8b 4.1±0.2ac 4.5±0.2ac 3.5±0.5c 0.4±0.02d 9.9±0.5b 10.0±0.3b
% LC PUFA 16.6±2.2a 18.6±0.8a 36.8±1.1b 38.8±1.0b 23.6±3.1a 22.9±1.4a 30.9±2.7b 31.7±0.9b
% SFA 39.1±1.1ab 40.3±0.2a 41.4±0.6ab 36.4±0.2a 38.2±1.3a 37.1±0.8a 44.2±0.5b 41.6±2.7ab
% MUFA 27.3±0.4a 20.6±0.7abc 19.0±1.4bc 16.3±0.9c 24.2±2.7ab 28.3±0.7a 22.5±1.9abc 24.4±3.3abc
% PUFA 33.6±1.3a 39.1±0.7ab 39.7±0.8ab 41.2±3.5b 37.7±1.7ab 34.6±1.0a 33.3±2.3a 34.1±0.8a
% n-6 27.1±0.4a 24.4±0.8a 35.4±0.7b 36.4±0.9b 21.7±1.9c 27.9±1.3a 10.7±0.7d 11.6±0.1d
% n-3 6.5±0.5a 14.7±0.9b 4.3±0.2a 4.8±0.3a 16.0±1.0b 6.7±0.5a 22.6±1.6c 22.5±0.9c
n-6:n-3 ratio 4.3±0.4a 1.7±0.1b 8.2±0.3c 7.6±0.2c 1.4±0.2b 4.3±0.6a 0.5±0.01d 0.5±0.03d
⁎ CO, corn oil; SFA, saturated fatty acids; MUFA, monounsaturated fatty acids. Values are means ± SEM and within each row values not sharing a lower case letter differ (P≤0.05).
33J.M. Monk et al. / Journal of Nutritional Biochemistry 32 (2016) 29–38groups (Fig. 3E). Production of IL-6 and IL-1β did not differ between
either n-3 FA-enriched (i.e. ALA vs. EPA/DHA) or n-6 FA-enriched (i.e.
LA vs. AA) dietary groups. When comparing FA with similar chain
lengths (i.e. parent FA: LA vs. ALA), production of IL-6 was reduced byFig. 1. Percentage of splenic A) CD4+ T cells, B) CD8+ T cells and C) MHC II+ cells in unchalleng
group) and bars not sharing a lower case letter differ (P≤ .05). Data was analyzed by two-way43% and IL-1β was reduced by 42% in the ALA group (Fig. 3B-C).
Similarly, comparison of the LC FA products showed that IL-6
production was reduced by 52% and IL-1β was reduced by 34% in
the EPA/DHA group compared to AA (Fig. 3B-C). There were noed WT and D6KO mice. Bars represent mean values ± SEM (n=8–10/genotype/dietary
ANOVA (main effects: diet x genotype) and all P values are shown.
Fig. 2.Mononuclear cell ex vivo LPS-stimulated cytokine secretion. A) TNFα, B) IL-1β, C) IL-6, D) IL-10 and E) IFNγ. Bars representmean values± SEM (n=8/group) and bars not sharing
a lower case letter differ (P≤ .05). Data was analyzed by two-way ANOVA (main effects: diet x genotype) and all P values are shown.
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Contrary to the pro-inﬂammatory cytokine secretory proﬁle of AA in
response to TCR stimulation, production of the anti-inﬂammatory
cytokine IL-10 was reduced in the AA-enriched group compared to
EPA/DHA (−61%), ALA (−31%) and LA (−24%) (Fig. 3D).3.6. Cytokine response to anti-CD40 stimulation
Cytokine production in response to anti-CD40 stimulation is
shown in Supplemental Fig. 2. There was no difference between
dietary groups or genotypes in the production of any inﬂam-
matory cytokines (TNFα, IL-1β, IL-6 and IFNγ) in response to
anti-CD40 stimulation. Conversely, the EPA/DHA-enriched diet
increased IL-10 production compared to the LA-enriched and
AA-enriched dietary groups by 45% and 60%, respectively,
whereas there was no difference between the ALA-enriched
diet and any other dietary group.4. Discussion
The D6KOmouse used in this study is unable to metabolize dietary
essential FA into their respective downstream LC FA counterparts [1],
thereby providing a novel model to identify the immunomodulatory
effects of speciﬁc dietary FA. Therefore, we measured the percentage
of two major splenic inﬂammatory cytokine producing immune cell
subsets and the subsequent cytokine production proﬁle in response to
speciﬁc stimulation conditions as an output of immune function with
the view to gain a better understanding of the unique contributions of
individual FA to this component of immune competence. The key
ﬁndings from this study demonstrated that both the percentage of
CD4+ T cells (Fig. 1) and LPS-induced IFNγ secretion (Fig. 2) were
reduced in D6KO mice consuming the LA-enriched diet compared to
WT, suggesting that these parameters are dependent, at least in part,
on either conversion of LA to AA or dietary sources of AA. An additional
key ﬁnding determined by utilizing the D6KO mouse model, was the
independent effects of parent dietary essential FA (LA and ALA) from
Fig. 3.Mononuclear cell ex vivo TCR-stimulated cytokine secretion. A) TNFα, B) IL-1β, C) IL-6, D) IL-10 and E) IFNγ. Bars representmean values±SEM (n=8/group) and bars not sharing
a lower case letter differ (P≤ .05). Data was analyzed by two-way ANOVA (main effects: diet x genotype) and all P values are shown.
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which tended to be more bioactive compared to their respective
parent FA. Speciﬁcally, these critical ﬁndings include the independent
immunomodulatory effects of ALA and the less inﬂammatory potency
of LA versus AA.
In terms of splenic immune cell populations, there was no effect of
diet on the percentage of splenic MHC II+-expressing cells (i.e. APCs
comprised of dendritic cells,macrophages andB cells, Fig. 1), however,
the percentage of splenic CD8+ T cellswas reduced inmice consuming
the EPA/DHA-enriched diet (Fig. 1), as seen previously [58]. The
percentage of splenic CD4+ T cells did not differ between WT and KO
mice in any dietary group except for the LA-enriched diet, wherein
D6KO mice exhibited a reduction in CD4+ T cells to a similar level as
that observed in the EPA/DHA group (Fig. 1). These data suggest that
the conversion of LA to AAplays a role in sustaining splenic CD4+T cell
numbers and further study is required to determine the effect, if any,
of dietary FA on other splenic immune cell populations.
In terms of cytokine production under various stimulation
conditions the ability to desaturate FA (i.e. genotype) had very
little impact on cytokine production with the exception of IFNγ.
Speciﬁcally, in response to LPS stimulation, IFNγ production wasreduced in LA-fed D6KO mice compared to LA-fed WT and both WT
and D6KO AA-fed mice (which did not differ from each other, Fig. 2E).
Therefore, when AA is provided directly in the diet (i.e. AA-fedWT and
D6KO mice) or when conversion of LA to AA is permitted (i.e. LA-fed
WT mice) it potently stimulates IFNγ production in comparison to all
other FA. Therefore, LPS-stimulated IFNγ production is dependent
upon conversion from LA to AA, when dietary sources of AA are not
provided. This data also shows that AA, but not LA, is the primary
molecule needed for IFNγ production. Additionally, a more funda-
mental question is addressed by these data pertaining to the
inﬂammatory nature of n-6 FA parent versus FA conversion product
(LA versus AA), wherein LPS-stimulated IFNγ production only
increased in AA-fed D6KO and not LA-fed D6KO mice, indicating that
LA is not inherently inﬂammatory under this condition. Thus, the
D6KO model provides important evidence that IFNγ production is
dependent upon AA and not LA. It is only through conversion to AA
that LA becomes inﬂammatory. This ﬁnding is translationally relevant
in light of evidence demonstrating that conversion efﬁciency is not the
same in all individuals due to genetic polymorphisms present in the
delta 6 desaturase enzyme and may be low in some individuals [59].
This provides the ﬁrst evidence to our knowledge of an AA-speciﬁc
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only IFNγ levels were impacted by the ability to desaturate dietary
essential FA, this does not preclude a potential effect on other aspects
of immune function and further study is warranted.
Since LPS stimulated IFNγ production was the only cytokine
endpoint affected by Fads2 status (i.e. FA conversion potential), all
other effects of dietary FA on cytokine production can be generalized
to the effects of the dominant FA provided in the diet (LA, AA, ALA, and
EPA/DHA). In this connection, AA was more potent compared to LA in
promoting a pro-inﬂammatory cytokine secretory proﬁle in response
to LPS (e.g. TNFα and IL-6 levels) and TCR stimulation (e.g. IFNγ),
whereas EPA/DHA exhibited the strongest anti-inﬂammatory effect.
LC PUFAare typically consideredmore bioactive in comparison to their
respective parent FA, however, in this study we were able to conﬁrm
that these generalizations are not entirely correct through two critical
novel observations, i) that LA is not exclusively pro-inﬂammatory (e.g.
no difference between LA and n-3 PUFA groups in LPS-stimulated
TNFα or TCR-stimulated IFNγ), which highlights that the inﬂamma-
tory nature of LA is context-dependent (i.e. type of stimulus and
inﬂammatory cytokine produced), and ii) that ALA can exert
independent effects from EPA/DHA. The ﬁnding that LA does not
always exert an independent pro-inﬂammatory effect in comparison
to AA challenges the interpretation in FA immunobiology that all n-6
PUFA species are pro-inﬂammatory; supported by observations that
n-6 PUFA have been shown to i) enhance the severity of some
autoimmune diseases, ii) have high plasma levels associated with
certain inﬂammatory pathologies and iii) eicosanoids derived from n-
6 PUFA are classically pro-inﬂammatory (reviewed elsewhere [46]).
However, in these studies, control of n-6 PUFA conversion from LA to
AA was not possible until the development of the D6KO mouse. The
use of the D6KO mouse also permitted the novel ﬁnding of speciﬁc
immunomodulatory effects of ALA that could not be deﬁnitively
discerned in previous studies due to the confounding effect of
conversion to EPA and/or DHA [40–43], despite the low conversion
efﬁciency [2–5]. Our data show that ALA was as potent as EPA/DHA in
reducing inﬂammatory cytokine production in response to LPS (IL-6
and IL-1β) and TCR (IL-6, IL-1β and IFNγ) stimulation, thereby
demonstrating that ALA is more than simply a precursor for LC n-3 FA,
but instead exerts an independent biological effect. These data build
on previous work demonstrating the independent bioactivity of ALA
using the D6KO mouse in a model of fatty liver disease [47] and
highlight the need to critically assess the independent effects of ALA,
particularly since ALA is the most widely consumed n-3 PUFA in the
human diet [60]. Collectively, these data demonstrate the speciﬁc
inﬂuence of both n-3 andn-6 FA, provided at these levels in the diet, on
splenic immune cell populations which serve as the main cellular
source of cytokines produced in response to either cellular compartment
speciﬁc (i.e. anti-CD40,APCandTCR, T cells) or broad inﬂammatory (LPS)
stimuli. Moreover, this data provides the rationale for the use of the
D6KO model as a means to evaluate the biological effects of speciﬁc FA
andmore broadly the use of dietary FA-speciﬁc enrichment strategies to
modify aspects of immune function to promote optimal health and
immune competence.
Phenotypic signs of LC FA deﬁciency in D6KO mice, such as
dermatitis and intestinal ulcers, typically do not manifest until
approximately 17–21 weeks of age [50]. This delayed onset in FA
deﬁciency symptoms reﬂects the conservation of tissue LC FA levels
(i.e. AA and DHA) in D6KO mice as demonstrated in multiple tissues
wherein both gene expression and in vivo D6D activity is conﬁrmed to
be absent [50]. Moreover, FA depletion occurs at different rates
depending on the tissue site (i.e. brain versus heart) which likely
reﬂects their FA tissue-speciﬁc physiologic roles [50]. Therefore, the
low levels of AA and DHA in D6KO mice consuming the LA-enriched
and EPA/DHA-enriched diets do not reﬂect incomplete Fads2 deletion,
but instead reﬂect the preservation of maternal carryover-derived LCFA, and the possible conditional essentiality of these FA presumably
due to their roles in membrane composition, ﬂuidity and
cellular function [57]. The lack of FA deﬁciency symptoms in our
study (mice 12 weeks of age) also demonstrates the utility of the
D6KOmodel in studies of a shorter duration, wherein extension of our
study would result in further tissue depletion of LC FA and associated
complications.
In a typical human diet, where the relative intake of ALA is low, yet
LA is consumed in 5- to 20-fold greater amounts [6,7,9], the bulk
phospholipid detected in immune cells is reported to contain
approximately 20% AA and low levels of EPA (1%) and DHA (2.5%)
[25,40,61–64], although these proportions are altered in different
phospholipid classes [65]. Dietary enrichment of the n-3 FAmembrane
composition is well-documented in human mononuclear cells and
occurs in a dose-dependentmanner, reachingnear-plateau levels after
4 weeks of supplementation, followed by a small rise after 8 and
12 weeks [61–63]. Therefore, we utilized a 9-week supplementation
period and showed signiﬁcant splenic enrichment in both n-3 and n-6
FA species (Table 3). Generally, increased membrane phospholipid
content of n-3 PUFA occurs at the expense of n-6 PUFA, particularly AA
[61], and this fundamental change in PUFAmembrane content is likely
to underlie the differential biological effects observed in mice
consuming the AA-enriched versus EPA/DHA-enriched diets. A partial
explanation for the varying effects of n-3 and n-6 classes of FAmay be
due to their differential effects on lipid rafts, which are highly ordered
membrane microdomains that form platforms to facilitate signaling
events [66,67]; the composition and organization of which is
disrupted by n-3 PUFA [68,69]. Both toll-like receptor-4 andmembers
of its signaling complex [70–73] as well as TCR and associated signal-
transducing molecules required to sustain T cell activation [74]
localize within lipid rafts and n-3 PUFA have been shown to
disrupt downstream signaling of these pathways [75–80], and
therefore, a lipid raft-mediated mechanism may underlie the
downstream effects of n-3 PUFA on cytokine production, although
further study is required.
A limitation of our study design is the use of dietary amounts of LA,
ALA, AA, EPA and DHA that exceeds typical human intakes that would
be equivalent to 10–20 g, although in human intervention trials
higher doses of LC n-3 PUFA are required to achieve anti-inﬂammatory
effects (reviewed [81]). The approach used in the present studywas to
demonstrate, as a ﬁrst step, potential differences arising from each
unique FA. These data establish a foundation for further research using
physiologically relevant levels of these FA comparable to human diets.
Nevertheless, our work still provides potential for translation to
humanswith regard to the outcomes of our study and use of the D6KO
mouse model, since humans are poor converters of parent FA (LA and
ALA) into their downstream LC conversion product FA [7], and
therefore, are similar to knockout mice. This highlights the utility of
this mouse model in terms of attributing biological effects to speciﬁc
FA or in generating dietary strategies to attenuate chronic diseases.
Moreover, Fads2 deﬁciency underlies rare pathologies such as
Sjögren-Larsson syndrome and altered enzymatic D6D activity
inﬂuences the phenotype and severity of several chronic diseases
including cardiovascular disease, non-alcoholic steatohepatitis, insu-
lin resistance, neurological disorders such as schizophrenia and
certain types of cancer [82].
A component surrounding the interpretation of the immunomod-
ulatory effects of FA is the oversimpliﬁed interpretation of inﬂamma-
tory outcomes, wherein increased anti-inﬂammatory responses
mediated by n-3 PUFA are interpreted to be beneﬁcial, when in reality
a robust inﬂammatory response represents a normal physiological
function and only uncontrolled inﬂammatory responses in disease
states are deleterious. This further highlights the contextual depen-
dency of individual FA effects and the need for critical reassessment of
FA immunomodulatory potential. Assessment of immune function
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types and effector functions involved, which can exhibit overlapping
and redundant biological effects, thereby resulting in no singlemarker
of immune competence or immune function [83]. Consequently it is
challenging to comprehensively determine the effects of speciﬁc FA on
immune function. For example, the effect of n-3 PUFA supplementa-
tion (i.e. EPA/DHA) on various aspects of immune function including
phagocytosis, respiratory burst, antigen presentation, T-cell reactivity,
immunoglobulin, cytokine and lipid-mediator production have been
investigated (reviewed elsewhere [9,10,16,61]), but require revisita-
tion utilizing the D6KO model to deﬁnitely determine the speciﬁc
immunomodulatory effects of EPA/DHA versus ALA. Previously, others
have reported changes in mononuclear cell cytokine production in
response to various stimulatory conditions, however, in many cases
these studies fail to discern the effects of speciﬁc FA due to either
mixeddietary FAproﬁles and/or failure to account for the confounding
effect of downstreamconversion of LA to AA [27,31,34,40,42] or ALA to
EPA/DHA [31,40–42,84]. Further, several studies assessing the effects
of EPA and DHA on cytokine production have only utilized an LA-
enriched diet as a means for comparison, thereby overlooking the
independent immunomodulatory effects of n-6 FA and/or assuming
adverse effects of LA [27,30,31,40,42]. The cytokine response in
healthy (disease-free) mononuclear cells reﬂects baseline immunor-
esponsiveness, wherein the ability to respond appropriately to
inﬂammatory and/or immune cell compartment speciﬁc stimuli
reﬂects a beneﬁcial response by the host. Therefore, n-3 PUFA-
mediated reduced responsiveness to such stimulimay reﬂect amodest
reduction in inﬂammatory immune competence. Conversely, in
inﬂammatory pathologies, the ability of n-3 FA to blunt themagnitude
and/or responsiveness to stimulationwould be beneﬁcial. Collectively,
this highlights that the overall immunomodulatory effect of individual
n-3 and n-6 FA is context-dependent, and therefore, the use of
targeted dietary FA enrichment strategies to modify aspects of
immune function to promote health should be considered.Acknowledgements
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